Opportunity for developers and marketers of EGFR inhibitors in Brazil and Mexico

[News]

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that patient access to premium-priced targeted cancer treatments in Brazil and Mexico is improving, creating an opportunity for developers and marketers of epidermal growth factor receptor (EGFR) inhibitors.

More... (http://www.news-medical.net/news/20120405/Opportunity-for-developers-and-marketers-of-EGFR-inhibitors-in-Brazil-and-Mexico.aspx)